Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -2.22% | 67.98 | 0.0% | $2165.55m | |
| NVAX | Novavax, Inc. | 7.89% | 134.23 | 96.5% | $1107.73m | |
| SRNE | Sorrento Therapeutics, Inc. | 5.01% | 13.03 | 1.5% | $767.74m | |
| GILD | Gilead Sciences, Inc. | -0.92% | 68.21 | 1.0% | $566.18m | |
| AMGN | Amgen, Inc. | -0.43% | 240.69 | 1.3% | $483.06m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.19% | 611.20 | 2.7% | $398.45m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.73% | 268.87 | 1.9% | $364.75m | |
| BNTX | BioNTech SE | 3.10% | 71.26 | 0.0% | $361.78m | |
| BIIB | Biogen, Inc. | -1.70% | 288.25 | 1.6% | $349.52m | |
| ILMN | Illumina, Inc. | 3.27% | 355.38 | 3.5% | $349.37m | |
| VXRT | Vaxart, Inc. | -1.58% | 9.06 | 0.0% | $258.53m | |
| ATNM | Actinium Pharmaceuticals, Inc. | 4.45% | 9.98 | 13.3% | $240.55m | |
| EBS | Emergent BioSolutions, Inc. | 4.20% | 135.01 | 6.4% | $195.98m | |
| MCRB | Seres Therapeutics, Inc. | 22.41% | 28.84 | 3.6% | $166.73m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.87% | 101.89 | 2.0% | $166.39m |
Company Profile
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.